Filter by
Filters
Filter results

Date

Report series

All publications

Miscellaneous

All miscellaneous
140 results found
Letter |
18 May 2020

South Africa’s patent laws threaten access to future COVID-19 medicines

In a letter to South African President Cyril Ramaphosa published today, the Fix the Patent Laws (FTPL) coalition outlined major concerns about the country's ability to access future treatments or vaccines for COVID-19. They point out that the country’s outdated patent laws ensure that when effective treatments become available, they will likely be too expensive and remain inaccessible to those in need.

Feature story |
07 May 2020

Measles is a steady, silent killer among COVID-19 in DRC, CAR and Chad

While much of the world’s attention is on battling the COVID-19 pandemic, which has now reached many countries in Africa, measles continues to silently kill large numbers of mostly children in the Democratic Republic of Congo (DRC), Central African Republic (CAR) and Chad. DRC – which has also been fighting an Ebola epidemic – declared a measles outbreak in June 2019. Chad’s measles outbreak has been raging for two years, since May 2018. CAR declared its measles outbreak in January this year.

Together, the outbreaks have infected hundreds of thousands of children and killed thousands more. Some kids die at home, never having reached proper medical care, or having been seen only by a traditional healer.

Blog |
26 January 2020

Affordable vaccines — is it really too much to ask for when we paid for the research?

In medical school we are given the impression that infectious diseases, while scary, are something we can handle with the right tools.

The thought of facing them without treatments or vaccines available never crossed my mind, but if it had, it would have been terrifying.

Yet, this was exactly what our teams faced when we responded to the 2014–16 Ebola virus outbreak in West Africa which killed more than 11,000 people.

Press release |

Pfizer and GSK’s HIV/AIDS division, ViiV, prevents children with HIV from getting needed medicine

MSF calls out ViiV Healthcare—a division of US and UK pharmaceutical corporations Pfizer and GlaxoSmithKline plus Japan’s Shionogi—for preventing children with HIV from getting child-appropriate formulations of a critical HIV medicine ...